1. Supplementary Figure 2 Shiota et al.Q1
Q2-Q4
Testosterone (quartile)
0.0
0.2
0.4
0.6
0.8
1.0 O v e r a l s u i t 2 4 6 8 10 12 14 16
Duration (years)
No.
at risk 1Q 23 22 17 6 2
2Q-4Q 64 50 31 20 12 B Q1
Q2-Q4
Testosterone (quartile)
P = *
0.0
0.2
0.4
0.6
0.8
1.0 S u r v i a l t e f o m p g s n 2 4 6 8 10
Duration (years)
No.
at risk 1Q 18 13 5 1
2Q-4Q 45 27 7 2
Supplementary Figure 2. (A) and (B) OS (A) and overall survival from the progression (B) in 87 patients treated with CAB stratified by the 1st quartile (Q1) and 2nd to 4th quartiles (Q2–Q4) of serum testosterone levels.